| Product NDC: | 17478-767 |
| Proprietary Name: | Progesterone |
| Non Proprietary Name: | Progesterone |
| Active Ingredient(s): | 200 mg/1 & nbsp; Progesterone |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 17478-767 |
| Labeler Name: | Akorn, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA200456 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20121004 |
| Package NDC: | 17478-767-10 |
| Package Description: | 100 CAPSULE in 1 BOTTLE, PLASTIC (17478-767-10) |
| NDC Code | 17478-767-10 |
| Proprietary Name | Progesterone |
| Package Description | 100 CAPSULE in 1 BOTTLE, PLASTIC (17478-767-10) |
| Product NDC | 17478-767 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Progesterone |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20121004 |
| Marketing Category Name | ANDA |
| Labeler Name | Akorn, Inc. |
| Substance Name | PROGESTERONE |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Progesterone [Chemical/Ingredient],Progesterone [EPC] |